Evidence map›Paper›PMID 42058431›Full record

ArticleFrontiers in medicine2026

Successful treatment of cutaneous small-vessel vasculitis with upadacitinib: a Case Report.

Xingmo Li, Zhuochen Wu, Xin Zhao, Lijuan Liu, Huichao Li, Guoqiang Zhang, Qing Zhu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xingmo Li *Department of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Zhuochen Wu *Department of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Xin ZhaoDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Lijuan LiuDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Huichao LiDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Guoqiang ZhangDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Qing ZhuDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous small-vessel vasculitis (CSVV) is a rare skin vasculitis that mainly affects small blood vessels and is often caused by certain drugs or diseases. When the condition is severe, skin ulcers may occur, accompanied by severe pain, which can affect daily life. This article reports a case in which the patient had a poor response to conventional corticosteroid therapy, with the condition continuing to deteriorate. Following 3 months of combination therapy with oral upadacitinib, the skin lesions nearly healed completely. This provides a new perspective for the treatment of CSVV and offers clinicians an additional treatment option.

Indexed as

cutaneous small-vessel vasculitisJAK inhibitormechanismtreatmentupadacitinib

Identifiers

PMID42058431
PMCPMC13122906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.